Capstone Therapeutics Announces Follow-On Public Offering

The latest announcement is out from Capstone Therapeutics ( (CAPS) ).

Capstone Holding Corp. announced the pricing of its follow-on public offering of 1,250,000 shares of common stock at $4.00 per share, aiming to raise $5 million in gross proceeds. The shares are approved for listing on the Nasdaq Capital Market under the ticker symbol ‘CAPS’ and began trading on March 6, 2025, with the offering closing on March 7, 2025. Joseph Gunnar & Co., LLC acted as the sole book-running manager for the offering, and the company granted underwriters a 45-day option to purchase an additional 187,500 shares.

More about Capstone Therapeutics

Capstone Holding Corp. is a building products distribution company based in Alsip, Illinois. The company has expanded its business both organically and through strategic acquisitions, focusing on products such as stone veneer, landscape stone, and modular masonry fireplaces. Capstone operates in 31 US states and generates over half of its revenue from brands it owns or controls.

YTD Price Performance: 13.09%

Average Trading Volume: 36,701

Technical Sentiment Consensus Rating: Buy

Current Market Cap: $490.2K

For an in-depth examination of CAPS stock, go to TipRanks’ Stock Analysis page.